doi: 10.3389/fnut.2025.1615671 Received 21 April 2025 Accepted 29 July 2025 Published 13 August 2025 Volume 12 - 2025 Edited by Ismael San Mauro Martn, CINUSA Group, Spain Reviewed by Simone Birgit Bayer, University of Otago, Christchurch, New Zealand Emanuela Ribichini, Sapienza University of Rome, Italy Aleksandar Sic, Advocate Illinois Masonic Medical Center, United States Updates Copyright 2025 Khan, Brnstad, Hillestad, Steinsvik, Hausken, Berentsen and Lied
Tirzepatide ( Mounjaro ), on the other hand, is a dual-action medication, acting both as a GLP-1 agonist and a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist
It is present in various foodsparticularly aged, fermented, or processed itemsand is also released endogenously during allergic reactions and inflammation
Our Wisconsin-based patients receive more than just medicationwe offer weekly check-ins, personalized coaching, and long-term weight management tools to help you stay on track and keep the weight off